Skip to content

Teladoc Health, Inc.

Public company
Headquarters
NEW YORK, New York
Ticker
TDOC
CIK
0001477449

WARN notices since 2024

0
None on record

Workers affected since 2024

0
Across 0 notices

Executive changes, last 12 months

5
3 appointments, 2 departures

Last event

Sep 25, 2026
Executive departureCLO departs: Adam C. Vandervoort

Workers affected over time

Cumulative workers in WARN notices since 2024

Not enough notices to chart yet.

Leadership

Role and personSinceChange
CLOAdam C. VandervoortSep 25, 2026Departed
CFOMichael GrasherAug 31, 2026Appointed
directorDavid B. Snow, Jr.Aug 13, 2026Departed

Related companies

Same industry and state, with recent events.

  1. Executive departure

    CLO departs: Adam C. Vandervoort

    Adam C. Vandervoort, Chief Legal Officer and Secretary of Teladoc Health, Inc., resigns the role, effective November 1, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: Chief Legal Officer and Secretary

    Source: SEC 8-K, filed Sep 25, 2026

  2. Executive appointment

    CLO appointed: Jonathan Dorfman

    Jonathan Dorfman was named Chief Legal Officer and Secretary of Teladoc Health, Inc.. Jonathan Dorfman succeeds Adam C. Vandervoort. The company reported the change in an 8-K that cites Item 5.02.

    Role: Chief Legal Officer and Secretary

    Source: SEC 8-K, filed Sep 25, 2026

  3. Executive appointment

    CFO appointed: Michael Grasher

    Michael Grasher was named Chief Financial Officer of Teladoc Health, Inc., effective August 31, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: Chief Financial Officer

    Source: SEC 8-K, filed Aug 31, 2026

  4. Executive departure

    director departs: David B. Snow, Jr.

    David B. Snow, Jr., director of Teladoc Health, Inc., retires the role, effective September 30, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: director

    Source: SEC 8-K, filed Aug 13, 2026

  5. Executive appointment

    director appointed: Mark V. Anquillare

    Mark V. Anquillare was named director of Teladoc Health, Inc., effective August 3, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: director

    Source: SEC 8-K, filed Aug 3, 2026

Last verified Nov 8, 2026